February 12, 2004Open Access

Variations and increase in use of statins across Europe: data from administrative databases

Key Points

Key points are not available for this paper at this time.

Abstract

Coronary heart disease remains a major cause of death in most European countries. 1 Statins lower blood cholesterol concentration and reduce the relative risk of coronary events by about 30% in both primary and secondary prevention. 2 Statins are widely and increasingly used in most European countries, although data on the extent of this are not generally available.

问 AI

Bookmark

View Full Paper

Cite This Study

Walley et al. (Thu,) studied this question.

synapsesocial.com/papers/6a23946e55bd20cf6fa6019b https://doi.org/https://doi.org/10.1136/bmj.328.7436.385

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The Public Health Approach1954 · 46 citations
2Age, sex and practice variations in the use of statins in general practice in England and Wales2000 · 62 citations
3EURO-MED-STAT: Monitoring expenditure and utilization of medicinal products in the European Union countries: a Public Health approach2003 · 15 citations
4EURO-MED-STAT - Monitoring expenditure and utilization of medicinal products in the European Union countries: a Public Health approach2003 · 21 citations
5Secondary prevention of ischaemic cardiac events.2002 · 13 citations

问 AI

Bookmark

View Full Paper